Two chronic myelogenous leukaemia cell lines which represent different stages of erythroid differentiation

Br J Haematol. 1993 Dec;85(4):653-62. doi: 10.1111/j.1365-2141.1993.tb03205.x.

Abstract

We established two cell lines, YN-1 and Y-1K, from the peripheral blood of two chronic myelogenous leukaemia patients in blastic crisis. Characterization of the YN-1 and Y-1K cells revealed that these cells expressed erythroid lineage markers. However, there was a marked difference in the level of gamma-globin mRNA and haemoglobin in YN-1 and Y-1K cells. YN-1 contained approximately 1-5% benzidine-positive staining cells, whereas no benzidine-positive cells were observed in Y-1K cells. Haemoglobin production in YN-1 cells was markedly increased with various chemical inducers of erythroid differentiation, but was not in Y-1K cells. In contrast, Y-1K cells expressed CD34 stem cell antigen and CD41 megakaryocyte-specific antigen. These observations suggested that, although both cell lines were committed to the erythroid lineage, each cell line represented a distinct differentiation stage in the erythroid differentiation programme. Y-1K seemed to correspond to an early stage of cells in erythroid lineage, whereas YN-1 represented a more advanced stage in human erythropoiesis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Differentiation
  • Dose-Response Relationship, Drug
  • Erythroblasts / ultrastructure
  • Erythroid Precursor Cells / metabolism
  • Erythroid Precursor Cells / pathology*
  • Female
  • Gene Rearrangement
  • Globins / analysis
  • Hemin / metabolism
  • Hemoglobins / biosynthesis
  • Humans
  • Karyotyping
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Male
  • Middle Aged
  • RNA, Messenger / analysis
  • Tumor Cells, Cultured*

Substances

  • Hemoglobins
  • RNA, Messenger
  • Hemin
  • Globins